OMV AG/ AT0000743059 /
1/24/2025 9:18:30 PM | Chg. -0.100 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
39.160EUR | -0.25% | 15,274 Turnover: 597,202.060 |
39.000Bid Size: 2,140 | 39.120Ask Size: 140 | 12.8 bill.EUR | 12.90% | 8.64 |
GlobeNewswire
3/26/2024
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16/2024
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center